Thiamine responsive megaloblastic anemia syndrome | |
---|---|
Specialty | Medical genetics |
Complications | Diabetes mellitus, anemia, hearing loss |
Causes | SLC19A2 gene mutation [1] |
Treatment | Thiamine |
Thiamine responsive megaloblastic anemia syndrome (also known as Rogers syndrome) is a very rare autosomal recessive genetic disorder affecting a thiamine transporter, which is characterized by megaloblastic anemia, diabetes mellitus, and hearing loss. The condition is treated with high doses of thiamine (vitamin B1).
In most cases (80-99%), people with this condition experience poor appetite (anorexia), diarrhea, headache, and lethargy. [1] Thiamine responsive megaloblastic anemia syndrome is associated with progressive sensorineural hearing loss. Additional manifestations include optic atrophy, short stature, enlarged liver, and an enlarged spleen. [2] Some cases may affect the heart, leading to abnormal heart rhythms. [3]
The condition is inherited in an autosomal recessive fashion, and is caused by a mutation in the SLC19A2 gene. [1]
This section is empty. You can help by
adding to it. (October 2021) |
Treatment consists of high doses of oral thiamine. Treatment can delay the onset of diabetes mellitus, and reverses anemia. If treatment is initiated early, thiamine deficiency can be prevented.[ citation needed]
The condition was first described in 1969 by Dr. Lon E. Rogers, a pediatric hematologist in Dallas, Texas.[ citation needed]
Thiamine responsive megaloblastic anemia syndrome | |
---|---|
Specialty | Medical genetics |
Complications | Diabetes mellitus, anemia, hearing loss |
Causes | SLC19A2 gene mutation [1] |
Treatment | Thiamine |
Thiamine responsive megaloblastic anemia syndrome (also known as Rogers syndrome) is a very rare autosomal recessive genetic disorder affecting a thiamine transporter, which is characterized by megaloblastic anemia, diabetes mellitus, and hearing loss. The condition is treated with high doses of thiamine (vitamin B1).
In most cases (80-99%), people with this condition experience poor appetite (anorexia), diarrhea, headache, and lethargy. [1] Thiamine responsive megaloblastic anemia syndrome is associated with progressive sensorineural hearing loss. Additional manifestations include optic atrophy, short stature, enlarged liver, and an enlarged spleen. [2] Some cases may affect the heart, leading to abnormal heart rhythms. [3]
The condition is inherited in an autosomal recessive fashion, and is caused by a mutation in the SLC19A2 gene. [1]
This section is empty. You can help by
adding to it. (October 2021) |
Treatment consists of high doses of oral thiamine. Treatment can delay the onset of diabetes mellitus, and reverses anemia. If treatment is initiated early, thiamine deficiency can be prevented.[ citation needed]
The condition was first described in 1969 by Dr. Lon E. Rogers, a pediatric hematologist in Dallas, Texas.[ citation needed]